Skip to main content
Watch Insiders
GLUE filings

Corporate insider profile

Markus Warmuth Filing Activity

Latest reported as President & CEO of Monte Rosa Therapeutics, Inc. (GLUE).

Purchase filings
0
Reported companies
1
Net open-market value
-$350,824.40
Latest transaction
Jun 1, 2026

Affiliated corporations

Reported company relationships

GLUELatest reported

Monte Rosa Therapeutics, Inc.

President & CEO

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 1, 2026Monte Rosa Therapeutics, Inc. (GLUE)President & CEOSale5,466$19.44$106,253
May 1, 2026Monte Rosa Therapeutics, Inc. (GLUE)President & CEOSale5,467$18.92$103,447
Apr 14, 2026Monte Rosa Therapeutics, Inc. (GLUE)President & CEOSale8,000$17.64$141,125